Announcement

New Lyphochek® Allergen sIgE Controls

HERCULES, CA –August 6, 2015 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global provider of life science research and clinical diagnostic products, announced the release of human-serum based Lyphochek® Allergen sIgE quality controls to monitor precision of in vitro allergy test procedures.

Lyphochek Allergen sIgE Control (Negative and Panel A) are multi-constituent controls that eliminate the need for multiple, single analyte controls. The controls are analyzed for 15 frequently tested allergen-specific immunoglobin E antibodies that include dust mites, mold, dander, foods and grasses. Quantitative insert values are provided for three commonly used, fully automated test systems.

“Bio-Rad is proud to be the largest independent provider of quality controls for in-vitro allergy testing,” said Anna Riviere, Bio-Rad Product Manager, Quality Systems. “Our consolidated controls mean fewer bottles are required and this results in cost savings, increased efficiencies, and less waste.”

When used with Bio-Rad’s Unity™ Interlaboratory Program, the world’s largest comparison peer group and Unity Real Time®, an expert data management software solution designed to improve the effectiveness of quality control processes, allergy testing laboratories are provided with the industry’s most complete solution for daily, optimized quality controls. In addition, Unity Interlaboratory Program participants are able to access their reports online at QCNet™.

Key Benefits
Lyphochek Allergen sIgE Control (Negative, and Panel A) are multi-constituent controls and are:

  • Designed for different instruments and reagent systems that are commonly used in laboratories worldwide
  • Offer an excellent three-year shelf life and reconstituted open-vial stability of 28 days when stored between 2°C to 8°C

For over 25 years Bio-Rad has been a leader in providing quality control products, technical support, as well as data management software solutions that improve the effectiveness of quality control processes. For more information, please call 1-800-2-BIORAD (1-800-224-6723) or visit www.bio-rad.com

About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) develops, manufactures, and markets a broad range of innovative products and solutions for the life science research and clinical diagnostic markets. The company is renowned for its commitment to quality and customer service among university and research institutions, hospitals, public health and commercial laboratories, as well as the biotechnology, pharmaceutical, and food safety industries. Founded in 1952, Bio-Rad is based in Hercules, California, and serves more than 100,000 research and healthcare industry customers through its global network of operations. The company employs more than 7,600 people worldwide and had revenues exceeding $2.1 billion in 2014. For more information, please visit www.bio rad.com

Press Contact:
Bio-Rad Laboratories, Inc.
Sue Seamon, Marketing Communications Manager
510-724-7000
Email: sue_seamon@bio-rad.com

 

Find Products & Information

Log In / Register

Log In / Register
PLEASE LOG IN NOT REGISTERED?
Login ID
Password